0001437749-22-027386.txt : 20221114 0001437749-22-027386.hdr.sgml : 20221114 20221114184328 ACCESSION NUMBER: 0001437749-22-027386 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221109 FILED AS OF DATE: 20221114 DATE AS OF CHANGE: 20221114 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: JORDEN DAVID EMERSON CENTRAL INDEX KEY: 0001313516 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32518 FILM NUMBER: 221388512 MAIL ADDRESS: STREET 1: 2635 TECHNOLOGY FOREST BLVD. CITY: THE WOODLANDS STATE: TX ZIP: 77381 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nuo Therapeutics, Inc. CENTRAL INDEX KEY: 0001091596 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 233011702 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 8285 EL RIO, SUITE 150 CITY: HOUSTON STATE: TX ZIP: 77054 BUSINESS PHONE: 832-236-9060 MAIL ADDRESS: STREET 1: 8285 EL RIO, SUITE 150 CITY: HOUSTON STATE: TX ZIP: 77054 FORMER COMPANY: FORMER CONFORMED NAME: Nuo Therapeutics, Inc DATE OF NAME CHANGE: 20141112 FORMER COMPANY: FORMER CONFORMED NAME: CYTOMEDIX INC DATE OF NAME CHANGE: 20000511 FORMER COMPANY: FORMER CONFORMED NAME: AUTOLOGOUS WOUND THERAPY INC DATE OF NAME CHANGE: 20000407 4 1 rdgdoc.xml FORM 4 X0306 4 2022-11-09 0001091596 Nuo Therapeutics, Inc. AURX 0001313516 JORDEN DAVID EMERSON C/O NUO THERAPEUTICS, INC. 8285 EL RIO, SUITE190 HOUSTON TX 77054 1 1 CEO/CFO Common Stock 2022-11-09 4 S 0 30000 1.50 D 2107858 D Common Stock 2022-11-09 4 S 0 30000 1.50 D 2077858 D Common Stock 2022-11-09 4 S 0 27000 1.50 D 2050858 D Common Stock 2022-11-09 4 S 0 20000 1.50 D 2030858 D Common Stock 2022-11-09 4 S 0 20000 1.50 D 2010858 D Common Stock 2022-11-09 4 S 0 13500 1.50 D 1997358 D Common Stock 2022-11-09 4 S 0 10000 1.50 D 1987358 D Common Stock 2022-11-09 4 S 0 7000 1.50 D 1980358 D Common Stock 2022-11-09 4 S 0 5000 1.50 D 1975358 D The transactions reported herein were made in private transactions to various persons whereby the shares of common stock acquired constitute "restricted" securities within the meaning of the Securities Act of 1933, as amended. /s/ David Jorden 2022-11-14